1,720,981 research outputs found
Culture filtrates and whole heat-killed Candida albicans stimulate human monocytes to release interleukin-6.
No full textThe release of TNF-alpha and IL-6 from human monocytes stimulated by filtrates of Candida albicans after treatment with amphotericin B.
No full textIndagine sieroepidemiologica nei riguardi dei virus HS, V/Z, CMV; MP in soggetti sottoposti a trapianto d'organo trattati con diversi farmaci immunosoppressori
No full textAztreonam biliary excretion in bile duct ligated jaundiced rats
No full textAn experimental study was undertaken to assess aztreonam biliary concentrations in bile duct ligated jaundiced rats. The study proved that aztreonam biliary concentrations are sufficient to inhibit Gram-negative bacteria within the first and the second hour after antibiotic administration. The experimental model suggests that clinical conditions such as lithiasis or neoplasms of the biliary tree should not totally inhibit the antibiotic excretion
Analisi di sieri indeterminati al test Riba di II generazione mediante test con antigeni proteici di sintesi
No full textIndagine sieroepidemiologica nei riguardi dei virus herpes simplex, varicella zoster, cytomegalovirus e mycoplasma pneumoniae in soggetti sottoposti a trapianto d'organo,trattati con diversi farmaci immunosoppressivi
No full textPolymerase Chain Reaction, with sequencing, as a diagnostic tool in culture-negative bacterial meningitis
No full text
Murine monoclonal antibody elicited with antibiotic-exposed Escherichia coli exerts protective capacity in experimental bacterial infections.
No full textEscherichia coli pre-exposed to a sub-minimal inhibitory concentration (sub-MIC) of several antibiotics elicits an enhanced humoral response which is protective against challenges with untreated homologous and heterologous bacteria. To characterise the specificity of this response we produced murine monoclonal antibodies (MAbs) to aztreonam-treated E. coli O6:K-. This resulted in the identification of MAb MT 1F, of isotype IgG1, that recognised a 12-kDa protein component of the untreated bacterial cells. After passive transfer, the MAb displayed protective activity in mice infected with lethal doses of live E. coli O6:K- and E. coli O111:B4. In ELISA experiments the MAb cross-reacted with structures located on whole cells of E. coli O6:K-, E. coli O111:B4, E. coli J5 and Salmonella minnesota Re595 and it also exerted a bactericidal activity against live E. coli O6:K-. The modifications induced by antibiotic treatment may unmask bacterial epitopes that may elicit the production of MAbs endowed with protective capacity
- …
